Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5203_Библиотеки_им_академика_М_И_Перельмана.pdf
3 The Basic Principles andPrecautions ofDrug Therapy
References
1. Wang X, Li S.Refractory status epilepticus. Springer Singapore; 2017.
2. Fisher RS, van Emde Boas W, Blume W, etal. Epileptic seizures and epilepsy: denitions
proposed by the International League Against Epilepsy (ILAE) and the International Bureau
for Epilepsy (IBE). Epilepsia. 2005;46(4):470–2.
3. Fisher RS, Acevedo C, Arzimanoglou A, etal. ILAE ofcial report: a practical clinical denition of epilepsy. Epilepsia. 2014;55(4):475–82.
4. Shih JJ, Ochoa JG. A systematic review of antiepileptic drug initiation and withdrawal.
Neurologist. 2009;15(3):122–31.
5. Leone MA, Giussani G, Nevitt SJ, etal. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for rst unprovoked seizure. Cochrane Database Syst Rev.
2021;5(5):CD007144.
6. Campos MS, Ayres LR, Morelo MR, etal. Efcacy and tolerability of antiepileptic drugs in
patients with focal epilepsy: systematic review and network meta-analyses. Pharmacotherapy.
2016;36(12):1255–71.
7. Campos MSA, Ayres LR, Morelo MRS, etal. Comparative efcacy of antiepileptic drugs for
patients with generalized epileptic seizures: systematic review and network meta-analyses.
Int J Clin Pharm. 2018;40(3):589–98.
8. Costa J, Fareleira F, Ascencao R, et al. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia.
2011;52(7):1280–91.
9. Nevitt SJ, Marson AG, Tudur Smith C. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev.
2019;7(7):CD001911.
10. Peters J, Vijiaratnam N, Angus-Leppan H.Tics induced by antiepileptic drugs: a pragmatic
review. J Neurol. 2021;268(1):321–36.
11. Lezaic N, Gore G, Josephson CB, etal. The medical treatment of epilepsy in the elderly: a
systematic review and meta-analysis. Epilepsia. 2019;60(7):1325–40.
12. Andrade C.Major congenital malformations associated with exposure to antiepileptic drugs
during pregnancy. J Clin Psychiatry. 2018;79(4)
13. Tomson T, Battino D, Bonizzoni E, etal. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530–8.
14. Veroniki AA, Rios P, Cogo E, etal. Comparative safety of antiepileptic drugs for neurological
development in children exposed during pregnancy and breast feeding: a systematic review
and network meta-analysis. BMJ Open. 2017;7(7):e017248.
15. Campbell E, Kennedy F, Russell A, etal. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland epilepsy and pregnancy registers.
J Neurol Neurosurg Psychiatry. 2014;85(9):1029–34.
16. Lamberink HJ, Otte WM, Geleijns K, etal. Antiepileptic drug withdrawal in medically and
surgically treated patients: a meta-analysis of seizure recurrence and systematic review of its
predictors. Epileptic Disord. 2015;17(3):211–28.
17. Lamberink HJ, Otte WM, Geerts AT, et al. Individualised prediction model of seizure
recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free
patients: a systematic review and individual participant data meta-analysis. Lancet Neurol.
2017;16(7):523–31.
18. Yao J, Wang H, Xiao Z. Correlation between EEG during AED withdrawal and epilepsy
recurrence: a meta-analysis. Neurol Sci. 2019;40(8):1637–44.
19. Stevelink R, Koeleman BPC, Sander JW, etal. Refractory juvenile myoclonic epilepsy: a
meta-analysis of prevalence and risk factors. Eur J Neurol. 2019;26(6):856–64.
20. Strozzi I, Nolan SJ, Sperling MR, etal. Early versus late antiepileptic drug withdrawal for
people with epilepsy in remission. Cochrane Database Syst Rev. 2015;2015(2):CD001902.
381
382
21. Park KM, Kim SE, Lee BI.Antiepileptic drug therapy in patients with drug-resistant epilepsy. J Epilepsy Res. 2019;9(1):14–26.
22. Semah F, Thomas P, Coulbaut S, etal. Early add-on treatment vs alternative monotherapy in
patients with partial epilepsy. Epileptic Disord. 2014;16(2):165–74.
23. Beghi E, Gatti G, Tonini C, et al. Adjunctive therapy versus alternative monotherapy in
patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic
controlled trial. Epilepsy Res. 2003;57(1):1–13.
24. Wilby J, Kainth A, Hawkins N, etal. Clinical effectiveness, tolerability and cost-effectiveness
of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health
Technol Assess. 2005;9(15):1–157. iii–iv
25. Sillanpaa M, Schmidt D.Natural history of treated childhood-onset epilepsy: prospective,
long-term population-based study. Brain. 2006;129(Pt 3):617–24.
26. Sillanpaa M, Saarinen M, Schmidt D.Clinical conditions of long-term cure in childhoodonset epilepsy: a 45-year follow-up study. Epilepsy Behav. 2014;37:49–53.
27. Kwan P, Brodie MJ. Early identication of refractory epilepsy. N Engl J Med.
2000;342(5):314–9.
28. Zuberi SM, Wirrell E, Yozawitz E, etal. ILAE classication and denition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE task force on
nosology and denitions. Epilepsia. 2022;63(6):1349–97.
29. Wilmshurst JM, Gaillard WD, Vinayan KP, et al. Summary of recommendations for the
management of infantile seizures: task force report for the ILAE Commission of Pediatrics.
Epilepsia. 2015;56(8):1185–97.
30. Epi PMC. A roadmap for precision medicine in the epilepsies. Lancet Neurol.
2015;14(12):1219–28.
31. Glauser T, Ben-Menachem E, Bourgeois B, etal. Updated ILAE evidence review of antiepileptic drug efcacy and effectiveness as initial monotherapy for epileptic seizures and
syndromes. Epilepsia. 2013;54(3):551–63.
32. Wirrell EC, Hood V, Knupp KG, etal. International consensus on diagnosis and management
of Dravet syndrome. Epilepsia. 2022;63(7):1761–77.
33. Besag FMC, Vasey MJ, Chin RFM.Evaluating fenuramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome. Expert Rev
Neurother. 2024;24(3):235–49.
34. Bergelson I, Walker C, Frank EL, et al. Felbamate urolithiasis. BMJ Case Rep.
2023;16(12):e253883.
35. Reif PS, Tsai MH, Helbig I, etal. Precision medicine in genetic epilepsies: break of dawn?
Expert Rev Neurother. 2017;17(4):381–92.
36. Cameld P, Cameld C.The frequency of intractable seizures after stopping AEDs in seizurefree children with epilepsy. Neurology. 2005;64(6):973–5.
37. De Clerck L, Nica A, Biraben A.Clinical aspects of seizures in the elderly. Geriatrie et psychologie neuropsychiatrie du vieillissement. 2019;17(S1):7–12.
38. Miskov S, Roje Bedekovic M, Mikula I, etal. Etiology and treatment of epilepsy in the elderly.
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti. 2005;59(1):63–7.
39. Bongomin F, Katabira E, Sajatovic M, etal. Epilepsy in older people in sub-Saharan Africa:
a systematic review. Neuropsychiatr Dis Treat. 2021;17:2309–14.
40. Moura L, Smith JR, Blacker D, etal. Epilepsy among elderly Medicare beneciaries: a validated approach to identify prevalent and incident epilepsy. Med Care. 2019;57(4):318–24.
41. Beghi M, Savica R, Beghi E, etal. Utilization and costs of antiepileptic drugs in the elderly:
still an unsolved issue. Drugs Aging. 2009;26(2):157–68.
42. Sanya EO. Peculiarity of epilepsy in elderly people: a review. West Afr J Med.
2010;29(6):365–72.
43. Tedrus G.Ictal EEG: etiology and mortality in older adults with nonconvulsive status epilepticus. Clin EEG Neurosci. 2024;55(2):278–82.
Q. Wang et al.
3 The Basic Principles andPrecautions ofDrug Therapy
44. Narayanan N, Selvaraj S, Mohamedkalifa A, et al. Seizure in geriatric population – an
unheeded integer. J Family Med Prim Care. 2023;12(4):644–8.
45. Suastegui Roman RA, Lee A, Hernandez Vanegas LE, et al. New-onset geriatric epilepsy in a Latin American country: a multi-centric study from Mexico. Rev Investig Clin.
2023;75(4):203–11.
46. Green SF, Loefad N, Heaney DC, etal. New-onset seizures in older people: clinical features, course and outcomes. J Neurol Sci. 2021;429:118065.
47. Verma A, Kumar A, Pathak P, et al. Clinical prole and predictors of in-hospital mortality in De novo convulsive status epilepticus in the elderly populace. J Epilepsy Res.
2022;12(2):48–52.
48. Watkins L, O'Dwyer M, Shankar R. New anti-seizure medication for elderly epileptic
patients. Expert Opin Pharmacother. 2019;20(13):1601–8.
49. Konickova D, Mensikova K, Klicova K, etal. Cerebrospinal uid and blood serum biomarkers in neurodegenerative proteinopathies: a prospective, open, cross-correlation study. J
Neurochem. 2023;167(2):168–82.
50. Nikl J.Epilepsy in the elderly. Ideggyogyaszati szemle. 2011;64(3–4):78–87.
51. Pervin S, Jicha GA, Bensalem-Owen M, etal. Incident epilepsy in the cognitively normal
geriatric population, irrespective of seizure control, impairs quality of life. Epilepsy Behav.
2022;126:108457.
52. Rohracher A, Trinka E. Epilepsy in the aged : challenges in diagnostics and treatment.
Zeitschrift fur Gerontologie und Geriatrie. 2021;54(4):395–408.
53. Lattanzi S, Trinka E, Del Giovane C, etal. Antiepileptic drug monotherapy for epilepsy in
the elderly: a systematic review and network meta-analysis. Epilepsia. 2019;60(11):2245–54.
54. Pohlmann-Eden B, Marson AG, Noack-Rink M, etal. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed
epilepsy: subgroup analysis of the randomized, unblinded KOMET study. BMC Neurol.
2016;16(1):149.
55. Verma A, Prasad Vaishya G, Mathew DJ, etal. Predictors of in-hospital mortality in epilepsy
and epileptic seizures in the elderly populace – a cross sectional study from rural India.
Epilepsy Res. 2021;171:106564.
56. Verma A, Kumar A, Sachan D.Comparison of clinical prole and outcome of de novo convulsive status epilepticus with those with a past history of epilepsy in the elderly populace.
Acta Neurol Taiwanica. 2022;31(3):131–6.
57. Fiest KM, Sauro KM, Wiebe S, etal. Prevalence and incidence of epilepsy: a systematic
review and meta-analysis of international studies. Neurology. 2017;88(3):296–303.
58. Pennell PB.Hormonal aspects of epilepsy. Neurol Clin. 2009;27(4):941–65.
59. Harden CL, Pennell PB.Neuroendocrine considerations in the treatment of men and women
with epilepsy. Lancet Neurol. 2013;12(1):72–83.
60. Herzog AG, Fowler KM.Sexual hormones and epilepsy: threat and opportunities. Curr Opin
Neurol. 2005;18(2):167–72.
61. Isojärvi JI, Taubøll E, Herzog AG.Effect of antiepileptic drugs on reproductive endocrine
function in individuals with epilepsy. CNS Drugs. 2005;19(3):207–23.
62. Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia.
2003;44(Suppl 4):11–20.
63. Morrell MJ, Flynn KL, Seale CG, etal. Reproductive dysfunction in women with epilepsy:
antiepileptic drug effects on sex-steroid hormones. CNS Spectr 2001;6(9):771–2, 83–86.
64. Svalheim S, Sveberg L, Mochol M, etal. Interactions between antiepileptic drugs and hormones. Seizure. 2015;28:12–7.
65. Isojärvi JI, Laatikainen TJ, Pakarinen AJ, etal. Polycystic ovaries and hyperandrogenism in
women taking valproate for epilepsy. N Engl J Med. 1993;329(19):1383–8.
66. Harden CL.Sexual dysfunction in women with epilepsy. Seizure. 2008;17(2):131–5.
67. Zelená V, Kuba R, Soška V, etal. Depression as a prominent cause of sexual dysfunction in
women with epilepsy. Epilepsy Behav. 2011;20(3):539–44.
383
384
68. Harden CL, Koppel BS, Herzog AG, etal. Seizure frequency is associated with age at menopause in women with epilepsy. Neurology. 2003;61(4):451–5.
69. Dutton C, Foldvary-Schaefer N.Contraception in women with epilepsy: pharmacokinetic
interactions, contraceptive options, and management. Int Rev Neurobiol. 2008;83:113–34.
70. Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS
Drugs. 2002;16(4):263–72.
71. Crawford P, Chadwick DJ, Martin C, etal. The interaction of phenytoin and carbamazepine
with combined oral contraceptive steroids. Br J Clin Pharmacol. 1990;30(6):892–6.
72. Dickins M, Chen C. Chemistry, biotransformation, and pharmacokinetics. Antiepileptic
drugs. Philadelphia: Lippincott Williams & Wilkins; 2002. p.370–9.
73. Battino D, Tomson T, Bonizzoni E, etal. Seizure control and treatment changes in pregnancy:
observations from the EURAP epilepsy pregnancy registry. Epilepsia. 2013;54(9):1621–7.
74. King A, Gerard EE.Contraception, fecundity, and pregnancy in women with epilepsy: an
update on recent literature. Curr Opin Neurol. 2022;35(2):161–8.
75. Bhatia M, Adcock JE, Mackillop L.The management of pregnant women with epilepsy: a
multidisciplinary collaborative approach to care. Obstetr Gynaecol. 2017;19(4):279–88.
76. Morrow J, Russell A, Guthrie E, etal. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg
Psychiatry. 2006;77(2):193–8.
77. Tomson T, Battino D, Bonizzoni E, etal. Declining malformation rates with changed antiepileptic drug prescribing: an observational study. Neurology. 2019;93(9):e831–e40.
78. Vajda FJE, O'Brien TJ, Graham JE, etal. The contribution of non-drug factors to fetal malformation in anti-seizure-medication-treated pregnancy. Epilepsy Behav. 2021;118:107941.
79. Meador KJ, Baker GA, Browning N, etal. Fetal antiepileptic drug exposure and cognitive
outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol.
2013;12(3):244–52.
80. Knight R, Wittkowski A, Bromley RL.Neurodevelopmental outcomes in children exposed to
newer antiseizure medications: a systematic review. Epilepsia. 2021;62(8):1765–79.
81. Spiegel R, Merius H.Principles of epilepsy Management for Women in their reproductive
years. Front Neurol. 2020;11:322.
82. Hernández-Díaz S, Werler MM, Walker AM, etal. Folic acid antagonists during pregnancy
and the risk of birth defects. N Engl J Med. 2000;343(22):1608–14.
83. Voinescu PE, Park S, Chen LQ, et al. Antiepileptic drug clearances during pregnancy and
clinical implications for women with epilepsy. Neurology. 2018;91(13):e1228–e36.
84. Pennell PB, Newport DJ, Stowe ZN, etal. The impact of pregnancy and childbirth on the
metabolism of lamotrigine. Neurology. 2004;62(2):292–5.
85. Harden CL, Pennell PB, Koppel BS, etal. Management issues for women with epilepsy—
focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels,
and breast-feeding: report of the Quality Standards Subcommittee and Therapeutics and
Technology Assessment Subcommittee of the American Academy of Neurology and the
American Epilepsy Society. Epilepsia. 2009;50(5):1247–55.
86. Knight MKS, Brocklehurst P, et al. Epilepsy in pregnancy. Royal College Obstetr
Gynaecol. 2016;
87. Breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827–41.
88. Davanzo R, Dal Bo S, Bua J, etal. Antiepileptic drugs and breastfeeding. Ital J Pediatr.
2013;39:50.
89. Ito S.Drug therapy for breast-feeding women. N Engl J Med. 2000;343(2):118–26.
90. Ip S, Chung M, Raman G, etal. A summary of the Agency for Healthcare Research and
Quality's evidence report on breastfeeding in developed countries. Breastfeed Med.
2009;4(Suppl 1):S17–30.
91. HALE T HTW.Medications and mothers' Milk. Hale Pub; 2012.
92. Veiby G, Bjørk M, Engelsen BA, etal. Epilepsy and recommendations for breastfeeding.
Seizure. 2015;28:57–65.
Q. Wang et al.
3 The Basic Principles andPrecautions ofDrug Therapy
93. Wilner AN, Sharma BK, Soucy A, etal. Common comorbidities in women and men with
epilepsy and the relationship between number of comorbidities and health plan paid costs in
2010. Epilepsy Behav. 2014;32:15–20.
94. Ruiz-Giménez J, Sánchez-Alvarez JC, Cañadillas-Hidalgo F, etal. Antiepileptic treatment in
patients with epilepsy and other comorbidities. Seizure. 2010;19(7):375–82.
95. Meier C, Kraenzlin ME. Antiepileptics and bone health. Ther Adv Musculoskelet Dis.
2011;3(5):235–43.
96. WHO. Epilepsy: a public health imperative. Geneva: World Health Organization; 2019.
Contract No.: Licence: CC BY-NC-SA 3.0 IGO
97. Keezer MR, Sisodiya SM, Sander JW.Comorbidities of epilepsy: current concepts and future
perspectives. Lancet Neurol. 2016;15(1):106–15.
98. Asadi-Pooya AA, Barzegar Z.Marital status in young adult patients with seizures: epilepsy
vs. functional seizures. Epilepsy Behav. 2021;121(Pt A):108066.
99. Jacoby A, Austin JK. Social stigma for adults and children with epilepsy. Epilepsia.
2007;48(Suppl 9):6–9.
100. Lim KS, Wo SW, Wong MH, etal. Impact of epilepsy on employment in Malaysia. Epilepsy
Behav. 2013;27(1):130–4.
101. Begley C, Wagner RG, Abraham A, etal. The global cost of epilepsy: a systematic review and
extrapolation. Epilepsia. 2022;63(4):892–903.
102. Hakami T. Neuropharmacology of Antiseizure drugs. Neuropsychopharmacol Rep.
2021;41(3):336–51.
103. Chen Z, Brodie MJ, Kwan P.What has been the impact of new drug treatments on epilepsy?
Curr Opin Neurol. 2020;33(2):185–90.
104. Perucca E, Brodie MJ, Kwan P, etal. 30 years of second-generation antiseizure medications:
impact and future perspectives. Lancet Neurol. 2020;19(6):544–56.
105. Kwan P, Arzimanoglou A, Berg AT, etal. Denition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia.
2010;51(6):1069–77.
106. Chen Z, Brodie MJ, Liew D, etal. Treatment outcomes in patients with newly diagnosed
epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort
study. JAMA Neurol. 2018;75(3):279–86.
107. Chen Z, Rollo B, Antonic-Baker A, et al. New era of personalised epilepsy management.
BMJ. 2020;371:m3658.
108. Nabbout R, Kuchenbuch M.Impact of predictive, preventive and precision medicine strategies in epilepsy. Nat Rev Neurol. 2020;16(12):674–88.
109. Walker LE, Mirza N, Yip VLM, etal. Personalized medicine approaches in epilepsy. J Intern
Med. 2015;277(2):218–34.
110. Chung WH, Hung SI, Hong HS, etal. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428(6982):486.
111. Bernasconi A, Antel SB, Collins DL, etal. Texture analysis and morphological processing
of magnetic resonance imaging assist detection of focal cortical dysplasia in extra-temporal
partial epilepsy. Ann Neurol. 2001;49(6):770–5.
112. Liu G, Xiao R, Xu L, etal. Minireview of epilepsy detection techniques based on electroencephalogram signals. Front Syst Neurosci. 2021;15:685387.
113. Mintz Y, Brodie R.Introduction to articial intelligence in medicine. Minim Invasive Ther
Allied Technol. 2019;28(2):73–81.
114. Falagario U, Veccia A, Weprin S, etal. Robotic-assisted surgery for the treatment of urologic
cancers: recent advances. Expert Rev Med Devices. 2020;17(6):579–90.
115. Barba P, Stramiello J, Funk EK, etal. Remote telesurgery in humans: a systematic review.
Surg Endosc. 2022;36(5):2771–7.
116. Najafabadipour M, Zanin M, Rodriguez-Gonzalez A, etal. Reconstructing the patient's natural history from electronic health records. Artif Intell Med. 2020;105:101860.
385
386
117. Middleton B, Sittig DF, Wright A.Clinical decision support: a 25 year retrospective and a 25
year vision. Yearb Med Inform. 2016;Suppl 1(Suppl 1):S103–16.
118. Shortliffe EH, Davis R, Axline SG, etal. Computer-based consultations in clinical therapeutics: explanation and rule acquisition capabilities of the MYCIN system. Comput Biomed
Res. 1975;8(4):303–20.
119. Abbasi MU, Rashad A, Basalamah A, etal. Detection of epilepsy seizures in neo-Natal EEG
using LSTM architecture. IEEE Access. 2019;7:179074–85.
120. Bzdok D, Krzywinski M, Altman N.Machine learning: supervised methods. Nat Methods.
2018;15(1):5–6.
121. Fix E, Hodges JL. Discriminatory analysis – nonparametric discrimination: consistency
properties. Int Stat Rev. 1989;57(3):238–47.
122. Hearst MA, Dumais ST, Osuna E, etal. Support vector machines. IEEE Intellig Syst Appl.
1998;13(4):18–28.
123. Chen T, Guestrin C, editors. XGBoost: a scalable tree boosting system2016: Association for
Computing Machinery.
124. Steyerberg E.Clinical prediction models: a practical approach to development, validation,
and updating. 2nd ed. NewYork: Springer International Publishing; 2019.
125. Devinsky O, Dilley C, Ozery-Flato M, etal. Changing the approach to treatment choice in
epilepsy using big data. Epilepsy Behav. 2016;56:32–7.
126. Ouyang CS, Chiang CT, Yang RC, etal. Quantitative EEG ndings and response to treatment
with antiepileptic medications in children with epilepsy. Brain Dev. 2018;40(1):26–35.
127. Zhang JH, Han X, Zhao HW, etal. Personalized prediction model for seizure-free epilepsy
with levetiracetam therapy: a retrospective data analysis using support vector machine. Br J
Clin Pharmacol. 2018;84(11):2615–24.
128. Jia Y, Gu H, Luo Q. Sample entropy reveals an age-related reduction in the complexity of
dynamic brain. Sci Rep. 2017;7(1):7990.
129. Jiang JL, Su X, Zhang H, et al. A novel approach to active compounds identication
based on support vector regression model and mean impact value. Chem Biol Drug Des.
2013;81(5):650–7.
130. Yao L, Cai M, Chen Y, etal. Prediction of antiepileptic drug treatment outcomes of patients
with newly diagnosed epilepsy by machine learning. Epilepsy Behav. 2019;96:92–7.
131. Petrovski S, Szoeke CE, Shefeld LJ, etal. Multi-SNP pharmacogenomic classier is superior to single-SNP models for predicting drug outcome in complex diseases. Pharmacogenet
Genomics. 2009;19(2):147–52.
132. Shazadi K, Petrovski S, Roten A, etal. Validation of a multigenic model to predict seizure
control in newly treated epilepsy. Epilepsy Res. 2014;108(10):1797–805.
133. Marson AG, Al-Kharusi AM, Alwaidh M, etal. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassiable epilepsy: an unblinded
randomised controlled trial. Lancet. 2007;369(9566):1016–26.
134. de Jong J, Cutcutache I, Page M, etal. Towards realizing the vision of precision medicine: AI
based prediction of clinical drug response. Brain. 2021;144(6):1738–50.
135. Terman SW.Rise of the machines? Predicting Brivaracetam response using machine learning. Epilepsy Curr. 2022;22(2):111–3.
136. Hakeem H, Feng W, Chen Z, et al. Development and validation of a deep learning model
for predicting treatment response in patients with newly diagnosed epilepsy. JAMA Neurol.
2022;79(10):986–96.
137. Ashish V, Noam S, Niki P, etal. Attention Is All You Need. Available from: https://arxiv.org/
abs/1706.03762
138. Lawn N, Chan J, Lee J, et al. Is the rst seizure epilepsy--and when? Epilepsia.
2015;56(9):1425–31.
139. Chiang S, Rao VR.Choosing the best Antiseizure medication – can articial intelligence
help? JAMA Neurol. 2022;79(10):970–2.
Q. Wang et al.
3 The Basic Principles andPrecautions ofDrug Therapy
140. Terman SW. Deep thoughts-predicting initial treatment response in newly diagnosed epilepsy. Epilepsy Curr. 2023;23(2):90–2.
141. Silva-Alves MS, Secolin R, Carvalho BS, etal. A prediction algorithm for drug response in
patients with mesial temporal lobe epilepsy based on clinical and genetic information. PLoS
One. 2017;12(1):e0169214.
142. Hastie T, Tibshirani R, Friedman J.The elements of statistical learning: data mining, inference, and prediction. 2nd ed. NewYork: Springer; 2009.
143. An S, Malhotra K, Dilley C, etal. Predicting drug-resistant epilepsy – a machine learning
approach based on administrative claims data. Epilepsy Behav. 2018;89:118–25.
144. Michalski R, Carbonell J, Mitchell T.Machine learning: an articial intelligence approach.
Springer Science & Business Media; 2013.
145. Brier G. Verication of forecasts expressed in terms of probability. Mon Weather Rev.
1950;78:1–3.
146. Niculescu-Mizil A, Caruana R, editors. Predicting good probabilities with supervised learning. The 22nd international conference on machine learning. Bonn, Germany; 2005.
147. Smolyansky ED, Hakeem H, Ge Z, etal. Machine learning models for decision support in
epilepsy management: a critical review. Epilepsy Behav. 2021;123:108273.
148. Delen D, Davazdahemami B, Eryarsoy E, etal. Using predictive analytics to identify drugresistant epilepsy patients. Health Informatics J. 2020;26(1):449–60.
149. Hirsch LJ, Gaspard N, van Baalen A, etal. Proposed consensus denitions for new-onset
refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES),
and related conditions. Epilepsia. 2018;59(4):739–44.
150. Feikes H, Smith LL, Hinshaw DB. Acute symptomatic postoperative hyponatremia. Am
Surg. 1964;30:505–10.
151. Varavithya W, Hellerstein S.Acute symptomatic hyponatremia. J Pediatr. 1967;71(2):269–83.
152. Pilke A, Partinen M, Kovanen J.Status epilepticus and alcohol abuse: an analysis of 82 status
epilepticus admissions. Acta Neurol Scand. 1984;70(6):443–50.
153. Hauser WA.Seizure disorders: the changes with age. Epilepsia. 1992;33 Suppl 4(s4):S6–14.
154. Grau-Lopez L, Flores-Pina B, Jimenez M, et al. Epileptiform electroencephalogram discharges increase seizure recurrence risk in patients with acute symptomatic seizure due to a
structural brain lesion. Seizure. 2024;117:56–9.
155. Pais-Cunha I, Almeida AI, Curval AR, etal. Cerebral venous thrombosis in pediatric age: risk
factors and prognosis. Neuropediatrics. 2024;55(3):183–90.
156. Hernandez-Prieto A, Garrido-Martin M, Gomez-Martin H, etal. Neonatal seizures and progression to epilepsy in a tertiary hospital. Rev Neurol. 2023;77(10):249–52.
157. Lekoubou A, Ssentongo P, Mafe J, etal. Associations of small vessel disease and acute
symptomatic seizures in ischemic stroke patients. Epilepsy Behav. 2023;145:109233.
158. Karan AA, Spivak YS, Suleymanova EM, etal. Distant neuroinammation acutely induced by
focal brain injury and its control by endocannabinoid system. Exp Neurol. 2024;373:114679.
159. Tsur A, Spierer R, Cohen R, etal. First unprovoked seizures among soldiers recruited to
the Israeli defense forces during 10 consecutive years: a population-based study. Epilepsia.
2024;65(1):127–37.
160. De Stefano P, Menetre E, Stancu P, etal. Added value of advanced workup after the rst
seizure: a 7-year cohort study. Epilepsia. 2023;64(12):3246–56.
161. Sinka L, Abraira L, Imbach LL, etal. Association of Mortality and Risk of epilepsy with type
of acute symptomatic seizure after ischemic stroke and an updated prognostic model. JAMA
Neurol. 2023;80(6):605–13.
162. Hersh N, Ben Zvi H, Goldstein L, etal. Epilepsy following herpes simplex encephalitis– a
case series. Epilepsy Res. 2023;192:107137.
163. Lopez-Espejo M, Skorin I, Mesa T, etal. Three-year incidence and acute setting predictors of
epilepsy after neonatal and childhood arterial ischaemic stroke: a disease-based cohort study.
Eur J Pediatr. 2024;183(3):1415–23.
387
388
164. Meletti S, Turchi G, Orlandi N, etal. Electrographic seizure duration and inter-seizure intervals in focal status epilepticus. Epileptic Disord. 2023;25(4):519–27.
165. Kim JW, Stetefeld HR, Fink GR, etal. Seizures at stroke onset: a case-control study. Seizure.
2023;113:28–33.
166. Agircan D, Bal M, Demir TG, etal. Multi-inammatory index as a new predictive and prognostic marker of acute symptomatic seizures in patients with cerebral venous sinus thrombosis. J Stroke Cerebrovasc Dis. 2023;32(12):107453.
167. Rodrigo-Gisbert M, Abraira L, Quintana M, etal. Risk assessment of long-term epilepsy after
de novo status epilepticus with clinical and electroencephalographic biomarkers: the AFTER
score. Epilepsy Behav. 2023;149:109531.
168. Rodrigo-Gisbert M, Gomez-Dabo L, Quintana M, etal. Prediction of long-term unprovoked
seizures after status epilepticus. Epilepsia. 2023;64(9):2399–408.
169. Tatillo C, Legros B, Depondt C, etal. Prognostic value of early electrographic biomarkers
of epileptogenesis in high-risk ischaemic stroke patients. Eur J Neurol. 2024;31(1):e16074.
170. Byrnes M, Thompson NR, Hantus ST, etal. Characteristics and attendance of patients eligible for the PASS clinic: a transition of care model after acute symptomatic seizures. Neurol
Clin Pract. 2024;14(1):e200232.
171. Tyvaert L.How autoimmunity changed our diagnostic practice in epileptology? Rev Neurol
(Paris). 2023;179(4):316–29.
172. Rada A, Bien CG.What is autoimmune encephalitis-associated epilepsy? Proposal of a practical denition Epilepsia. 2023;64(9):2249–55.
173. Byrnes M, Chandan P, Newey C, etal. Acute symptomatic seizure associated with chronic
Antiseizure medication use after stroke. Neurol Clin Pract. 2022;12(6):e154–e61.
174. Sortino V, Pratico A, Marino S, etal. Efcacy of the anti-seizure medications in acute symptomatic neonatal seizures caused by stroke. A systematic review. Acta bio-medica: Atenei
Parmensis. 2022;93(6):e2022328.
175. Zaccara G, Lattanzi S, Brigo F.Acute symptomatic seizures after stroke: a scoping review
on primary prevention, treatment with antiseizure medications and drug discontinuation.
Epilepsy Behav. 2023;149:109499.
176. Qiang J, Wang Y, Zhai Q, etal. Predictors of unprovoked seizures in intracerebral hemorrhages. Acta Neurol Belg. 2023;123(6):2195–200.
177. Herzig-Nichtweiss J, Salih F, Berning S, etal. Prognosis and management of acute symptomatic seizures: a prospective, multicenter, observational study. Ann Intensive Care.
2023;13(1):85.
178. Dalla Corte A, Pinzetta G, Ruwel AG, etal. Anatomical Organization of the Amygdala: a
brief visual review. Cogn Behav Neurol. 2024;37(1):13–22.
179. Shakhatreh L, Sinclair B, McLean C, etal. Amygdala enlargement in temporal lobe epilepsy:
histopathology and surgical outcomes. Epilepsia. 2024;65(6):1709–19.
180. Kaada BR, Andersen P, Jansen J Jr. Stimulation of the amygdaloid nuclear complex in
unanesthetized cats. Neurology. 1954;4(1):48–64.
181. Sawa M, Aida S, Hirasawa R, etal. Experimentally induced epilepsy by the local application of alumina cream into the amygdaloid nuclei in dogs. Folia Psychiatr Neurol Jpn.
1954;8(2):189.
182. Morris AA.Temporal lobectomy with removal of uncus, hippocampus, and amygdala; results
for psychomotor epilepsy three to nine years after operation. AMA Arch Neurol Psychiatry.
1956;76(5):479–96.
183. De Giacomo P.A hypothesis based on histochemical data regarding the site from which
originate the automatic movements present in rhinencephalic epilepsy and an added note
concerning the distribution of cholinesterase activity in the amygdaloid complex of man. Riv
Neurol. 1961;31:286–9.
184. Pagni CA.Electroclinical study of Amygdalo-Hippocampic after-discharges in man using
depth electrodes implanted by the stereotactic method. Conn Neurol. 1963;23:477–99.
Q. Wang et al.
3 The Basic Principles andPrecautions ofDrug Therapy
185. Yang YC, Wang GH, Chou P, et al. Dynamic electrical synapses rewire brain
networks for persistent oscillations and epileptogenesis. Proc Natl Acad Sci
USA. 2024;121(8):e2313042121.
186. Rhone AE, Kovach CK, Harmata GIS, etal. A human amygdala site that inhibits respiration
and elicits apnea in pediatric epilepsy. JCI Insight. 2020;5(6):e134852.
187. Nobis WP, Otárula KAG, Templer JW, etal. The effect of seizure spread to the amygdala on
respiration and onset of ictal central apnea. J Neurosurg. 2020;132(5):1313–23.
188. Dlouhy BJ, Gehlbach BK, Kreple CJ, etal. Breathing inhibited when seizures spread to the
amygdala and upon amygdala stimulation. J Neurosci. 2015;35(28):10281–9.
189. Maguire MJ, Jackson CF, Marson AG, etal. Treatments for the prevention of sudden unexpected death in epilepsy (SUDEP). Cochrane Database Syst Rev. 2020;2020(4):CD011792.
190. Legouhy A, Allen LA, Vos SB, et al. Volumetric and microstructural abnormalities of the
amygdala in focal epilepsy with varied levels of SUDEP risk. Epilepsy Res. 2023;192:107139.
191. Zeicu C, Legouhy A, Scott CA, etal. Altered amygdala volumes and microstructure in focal
epilepsy patients with tonic-Clonic seizures, Ictal and Post-Ictal Central Apnea. Cold Spring
Harbor Laboratory; 2023.
192. Ghazale PP, dos Santos Borges K, Gomes KP, et al. Alterations in aortic vasorelaxation
in rats with epilepsy induced by the electrical amygdala kindling model. Epilepsy Res.
2022;182:106920.
193. Marincovich A, Bravo E, Dlouhy B, etal. Amygdala lesions reduce seizure-induced respiratory arrest in DBA/1 mice. Epilepsy Behav. 2021;121:106440.
194. Bhasin H, Sharma S, Ramachandrannair R. Can we prevent sudden unexpected death in
epilepsy (SUDEP)? Can J Neurol Sci. 2021;48(4):464–8.
195. Faingold CL, Feng HJ.A unied hypothesis of SUDEP: seizure-induced respiratory depression induced by adenosine may lead to SUDEP but can be prevented by autoresuscitation and
other restorative respiratory response mechanisms mediated by the action of serotonin on the
periaqueductal gray. Epilepsia. 2023;64(4):779–96.
196. Somani A, Perry C, Patodia S, etal. Neuropeptide depletion in the amygdala in sudden unexpected death in epilepsy: a postmortem study. Epilepsia. 2020;61(2):310–8.
197. Campbell JM, Yost S, Gautam D, etal. Delays in the diagnosis and surgical treatment of drugresistant epilepsy: a cohort study. Epilepsia. 2024;65(5):1314–21.
198. Collard R, Aziz MC, Rapp K, etal. Galanin analogs prevent mortality from seizure-induced
respiratory arrest in mice. Front Neural Circ. 2022;16
199. Lacuey N, Hampson JP, Harper RM, et al. Limbic and paralimbic structures driving ictal
central apnea. Neurology. 2019;92(7):e655.
200. Tio E, Culler GW, Bachman EM, et al. Ictal central apneas in temporal lobe epilepsies.
Epilepsy Behav. 2020;112:107434.
201. Walker F, Fish DR.Recording respiratory parameters in patients with epilepsy. Epilepsia.
1997;38(11 Suppl):S41–2.
202. Schuele SU, Afshari M, Afshari ZS, etal. Ictal central apnea as a predictor for sudden unexpected death in epilepsy. Epilepsy Behav. 2011;22(2):401–3.
203. So EL, Sam MC, Lagerlund TL.Postictal central apnea as a cause of SUDEP: evidence from
near-SUDEP incident. Epilepsia. 2000;41(11):1494–7.
204. Vilella L, Lacuey N, Hampson JP, etal. Postconvulsive central apnea as a biomarker for sudden unexpected death in epilepsy (SUDEP). Neurology. 2019;92(3):e171–e82.
205. Joyal KG, Kreitlow BL, Buchanan GF.The role of sleep state and time of day in modulating
breathing in epilepsy: implications for sudden unexpected death in epilepsy. Front Neural
Circ. 2022;16:983211.
206. Micalizzi E, Ballerini A, Giovannini G, etal. The role of the amygdala in ictal central apnea:
insights from brain MRI morphometry. Ann Clin Translat Neurol. 2024;11(1):121–32.
207. Teran FA, Bravo E, Richerson GB.Sudden unexpected death in epilepsy: respiratory mechanisms. Handbook of clinical neurology: Elsevier; 2022. p.153–76.
389
390
208. Kim W, Lee H, Lee KW, etal. The Association of Nocturnal Seizures and Interictal Cardiac/
central autonomic function in frontal lobe epilepsy: heart rate variability and central autonomic network analysis. Neuropsychiatr Dis Treat. 2023;19:2081–91.
209. Zhao H, Long L, Xiao B.Advances in sudden unexpected death in epilepsy. Acta Neurol
Scand. 2022;146(6):716–22.
210. O’Neal TB, Shrestha S, Singh H, etal. Sudden unexpected death in epilepsy. Neurol Int.
2022;14(3):600–13.
211. Bosco F, Guarnieri L, Leo A, etal. Audiogenic epileptic DBA/2 mice strain as a model of
genetic reex seizures and SUDEP.Front Neurol. 2023:14.
212. Petrucci AN, Joyal KG, Chou JW, etal. Post-ictal generalized EEG suppression is reduced
by enhancing dorsal raphe serotonergic neurotransmission. Neuroscience. 2021;453:206–21.
213. Lacuey N, Martins R, Vilella L, et al. The association of serotonin reuptake inhibitors and
benzodiazepines with ictal central apnea. Epilepsy Behav. 2019;98:73–9.
214. Ito Y, Hata N, Maesawa S, et al. Characteristics of deceased subjects transported to a
postmortem imaging center due to unusual death related to epilepsy. Epilepsia Open.
2024;9(2):592–601.
Q. Wang et al.